Marker Therapeutics Changes in Working Capital (TTM) Analysis

Marker Therapeutics, Inc. (MRKR)

1.84 +0.13 (+7.60%) USD | NASDAQ | Jan 14, 16:00

1.84 0.00 (0.00%) After-Hours: 17:36

View Changes in Working Capital (TTM) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Changes in Working Capital (TTM) Chart

Start Trial

View Historical Data

Start Trial

View Changes in Working Capital (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Changes in Working Capital (TTM) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Viridian Therapeutics, Inc.	Upgrade
Neurocrine Biosciences, Inc.	Upgrade
Kiniksa Pharmaceuticals International Plc	Upgrade
AIM ImmunoTech, Inc.	Upgrade